MSD is a global research-based pharmaceutical company with a 125-year history with locations in over 140 countries and 69,000 employees. The head office is located in Kenilworth, NJ, USA.
In Sweden, MSD has 140 employees. The affiliate markets drugs and vaccines and carries out clinical trials.
Contact
Merck Sharp & Dohme (Sweden) AB
Gävlegatan 22
113 30 Stockholm, Sweden
Tel: +46 8 – 578 135 00
Mathias Uhlén is a world-renowned microbiology researcher at the KTH Royal Institute of Technology. Since 2003, he has led the Human Protein Atlas (HPA) project, an international effort to systematically…
Elisabeth Svanberg MD, PhD, a seasoned industry expert, having worked for established MNCs such as Serono, BMS & J&J, now sits on the board of Sweden’s national champion SOBI, is…
Tomer Feffer, Country Division Head Scandinavia & MD Bayer Sweden, shares his enthusiasm for Sweden’s innovative spirit and how Bayer is leveraging it through partnerships with medical technology and digital…
Sweden is considered a world leader in technology, and its innovative electronic health records system is in high demand by international researchers. Two key leaders of multinational pharma companies in…
Some of the key stakeholders in Swedish healthcare and life sciences outline why they feel Sweden’s capital, Stockholm, is a rising star in life sciences innovation. The Stockholm region…
Sweden is aiming to become a leading innovation nation in the life sciences, with the creation of a Life Sciences Office showing that the sector is right at the top…
Swedish biotech BioArctic, in collaboration with Japanese firm Eisai, has seen positive Phase IIb results for its BAN2401 antibody – potentially the first disease-modifying treatment for Alzheimer’s Disease and the…
Iddo Leshem, general manager Nordics at Bristol-Myers Squibb (BMS), talks about the uniqueness of Sweden’s collaborative culture and shatters some of the entrenched stereotypes about the country. He then breaks…
Eric Wahlberg, CEO of Uppsala University Hospital, Sweden´s oldest university hospital, explains his strategic vision of hospital management and how Uppsala is utilising e-health, precision medicine, clinical trials, small biotech…
Jakob Tellgren recently returned from MSD’s US headquarters to his home country of Sweden to take the helm of the Nordic and Baltic countries. He shares the importance of Sweden…
Karolinska Institutet (KI) is a centre of excellence for medical research and education in Sweden and the world. Ole Petter Ottersen has been the president of KI since 2017. Prior…
Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases. Mattias Bankel, Head of Nordics and Baltics, shares…
See our Cookie Privacy Policy Here
